The Carlat Psychiatry Report, Volume 2, Number 3, March 2004
Daniel Carlat, MD
Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Guess what: Antabuse (disulfiram) is back in fashion, over a half century after its initial approval by the FDA. You have probably seen some of the infomercials funded by Odyssey Pharmaceuticals and published as supplements by the usual journals.